The innovative medicine and medtech segments showed solid sales growth. Johnson & Johnson reported a strong increase in sales, but earnings fell due to one-time charges. In the wake of last year's ...
Johnson & Johnson's immunology superstar Stelara and oncology blockbuster Darzalex have long been among the company's top ...
Matt Miksic, an analyst from Barclays, maintained the Hold rating on Johnson & Johnson (JNJ – Research Report). The associated price ...
Johnson & Johnson reported third-quarter earnings with adjusted EPS of $2.42, surpassing expectations. Sales rose 5.2% to $22.47B. J&J updated its 2024 adjusted EPS guidance, lowering it slightly to ...
Olympian Alaysha Johnson's mission to revolutionize track and field, from challenging sponsor norms to advocating for ...
When Keldon Johnson first encountered new teammate Chris Paul this summer at the San Antonio Spurs’ Victory Capital ...
A super PAC closely linked to House Speaker Mike Johnson (R-La.) is putting money into defending former House Freedom Caucus ...
Speaker Mike Johnson (R-La.) announced a $27.5 million fundraising haul for the third quarter of the year, a sum that is ...
The Dwayne Johnson-starring Christmas-themed comedy adventure film “Red One” is set for a theatrical release in mainland ...
Few things are as important for a team as having a solid and reliable shortstop and figuring out who that player will be for ...
During an endorsement interview with The Kansas City Star Editorial Board, Vanessa Riebli, Democratic candidate for Johnson ...
JNJ's 3Q earnings expected to be $2.21 EPS and $22.16B revenue. Recent acquisitions and drug trials impacting stock's ...